| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |